Related Experiment Video
Updated: Aug 24, 2025

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
Smart dry powder inhalers and intelligent adherence management
Sabine Häußermann1, Laura J Arendsen1, John N Pritchard2
1VisionHealth GmbH, Munich, Germany.
Smart inhalers can monitor dry powder inhaler (DPI) use in chronic obstructive pulmonary disease (COPD) and asthma patients. This technology helps assess correct inhaler technique and adherence, crucial for effective disease management.
Area of Science:
- Respiratory Medicine
- Biomedical Engineering
- Digital Health
Background:
- Adherence to inhaled therapies for COPD and asthma is challenging, particularly correct administration technique with dry powder inhalers (DPIs).
- Patients often struggle with the rapid inhalation flow rates required for effective DPI use.
- Physicians face pressure to transition patients to DPIs due to environmental concerns regarding metered-dose inhaler propellants.
Purpose of the Study:
- To review technologies for monitoring DPI use in real-world settings.
- To evaluate the clinical effectiveness and patient/provider adoption of smart inhaler technologies for DPIs.
- To address the challenge of assessing patient inhaler technique outside of clinical environments.
Main Methods:
- Review of existing literature on smart inhaler technologies for DPI monitoring.
- Analysis of clinical effectiveness data from studies using these monitoring tools.
- Assessment of patient and healthcare provider adoption rates and feedback.
Main Results:
- Smart inhaler technologies offer a means to collect real-world data on DPI usage.
- Effectiveness in clinical settings and adoption by patients and providers vary and require further investigation.
- Monitoring DPI use is critical for ensuring disease control when transitioning inhaler types.
Conclusions:
- Smart inhalers represent a promising tool for improving adherence and technique in DPI users.
- Further research is needed to optimize the design and implementation of smart inhalers for widespread clinical adoption.
- Real-world data from smart inhalers can bridge the gap between clinical observation and actual patient behavior.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Asthma-IV: Nursing Management
First, in...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids

